Biopharma fundamentals: LCMS Biopharma characterization
Pharma and biopharma fundamentals masterclasses
Build confidence in your analytical decisions across pharma and biopharma workflows
The pharma and biopharma fundamentals masterclasses are a year-long educational series designed for scientists who want to strengthen their knowledge, compare analytical strategies, and apply best practices across regulated workflows.
Each session focuses on a real analytical challenge — from quantitation and metabolite identification to biopharma characterization and extractables and leachables — with practical guidance from SCIEX experts.
Attend live or watch on demand and choose the sessions most relevant to your work.
Available now:
Pharma fundamentals: Metabolite Identification Metabolite identification is essential in drug discovery, supporting confident decisions in compound design and toxicology
This session shows how alternative fragmentation strategies can overcome limitations of traditional CID and improve MetID accuracy for complex metabolites.
- Speaker: Heather Chassaing, Senior Accurate Mass Workflow Specialist, SCIEX
Upcoming sessions
1. Biopharma fundamentals: LCMS Biopharma characterization
This masterclass provides a practical introduction to LC-MS–based protein characterization for biopharmaceutical applications. Learn how to approach protein identity, purity, sequence, and post-translational modifications using established and alternative fragmentation strategies, with guidance on sample preparation, best practices, and troubleshooting to support reliable, high-quality results.
Speaker: Stephen Lock, Sr. Market Development Manager – Biopharma, SCIEX
Steve obtained his PhD in Physical Organic Chemistry from the University College of Swansea in 1993 and is a chartered chemist and a member of the Royal Society of Chemistry. He has worked for SCIEX in various technical roles for over 20 years and has presented at over 80 international meetings around the world. He currently works closely with customers in the biopharmaceutical industry. Steve is also currently an Adjunct Professor at the University of Pannonia.
